Notices of Intent to Revise and Pharmacopeial Forum-Related Notices

<64> Probiotic Tests Notice of Intent to Revise (posted 30-Jun-2023)
<621> Chromatography Notice of Intent to Revise (posted 06-Jan-2023)
<621>Chromatography Notice of Intent to Revise (posted 25-Aug-2023)
<660> Container-Glass (posted 27-Jan-2023)
<1079.2> Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products (posted 27-Jan-2023)
Albuterol Inhalation Solution Notice of Intent to Revise (posted 29-Sep-2023)
Bacillus coagulans Notice of Intent to Revise (posted 28-Apr-2023)
Bumetanide and Bumetanide Tablets Notice of Intent to Revise (posted 27-Oct-2023)
Cetyl Palmitate Notice of Intent to Revise (posted 23-Feb-2024)
Changes to General Notices, Section 1 (posted 28-Feb-2024)
Chemical Information Updates (posted 28-Apr-2023)
Clonidine Transdermal System Notice of Intent to Revise (posted 27-Oct-2023)
Clonidine Transdermal Systems: Removal of the Test for Organic Impurities (posted 24-Feb-2023)
Dapsone Tablets Notice of Intent to Revise (posted 23-Feb-2024)
Dutasteride and Tamsulosin Hydrochloride Tablets Notice of Intent to Revise (posted 28-Jul-2023)
Etidronate Disodium Notice of Intent to Revise (posted 27-Oct-2023)
Erythromycin Ethylsuccinate for Oral Suspension (posted 27-Jan-2023)
Fosfomycin Tromethamine (posted 28-Apr-2023)
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets Notice of Intent to Revise (posted 29-Dec-2023)
Gadopentetate Dimeglumine Injection Notice of Intent to Revise (posted 29-Dec-2023)
General Chapters Affected by Omission to <1118> Monitoring Devices- Time, Temperature, and Humidity (posted 18-Apr-2023)
General Chapters Affected by Revision to <1724> Semisolid Drug Products- Performance Tests (posted 28-Apr-2023)
General Chapters Affected by Revisions to <1912> Measurement of Yield Stress of Semisolids (posted 28-Apr-2023)
Glucagon for Injection Notice of Intent to Revise (posted 31-Oct-2023)
Gramicidin Notice of Intent to Revise (posted 25-Aug-2023)
I pratropium Bromide (posted 28-Apr-2023)
Lactobacillus acidophilus Notice of Intent to Revise(posted 30-Jun-2023)
Ligilactobacillus salivarus Notice of Intent to Revise (posted 30-Jun-2023)
Magaldrate Family of Monographs Notice of Intent to Revise (posted 28-Jul-2023)
Methscopolomine Bromide Tablets Notice of Intent to Revise (posted 28-Jul-2023)
Methylprednisolone Injectable Suspension Notice of Intent to Revise (posted 23-Feb-2024)
Monographs Affected by Revision to <616> Bulk Density of Powders (posted 28-Apr-2023)
Norgestimate Notice of Intent to Revise (posted 25-Aug-2023)
Polyethylene Glycol Notice of Intent to Revise (posted 23-Feb-2024)
Proposal to Add Flexibility in the Selection of Suitable Packaging and Storage for Parenteral Drugs (posted 27-Jan-2023)
Roflumilast Notice of Intent to Revise (posted 23-Feb-2024)
Sitagliptin Tablets Notice of Intent to Revise (posted 30-Jun-2023)
Sodium Bicarbonate (posted 03-Apr-2023)
Starch TS Notice of Intent to Revise (posted 25-Aug-2023)
Succinic Acid Notice of Intent to Revise (posted 12-Apr-2024)
Sucrose Notice of Intent to Revise (posted 31-Mar-2023)
Sucrose Notice of Intent to Revise (posted 23-Feb-2024)
Teniposide Notice of Intent to Revise (posted 27-Oct-2023)
Tobramycin Inhalation Solution Notice of Intent to Revise (posted 27-Oct-2023)
Zinc Family of Monographs Notice of Intent to Revise (posted 25-Aug-2023)
Zinc Sulfate Injection Notice of Intent to Revise (posted 28-Jul-2023)